Burden of risk variants correlates with phenotype of multiple sclerosis

Multiple Sclerosis

Volumn 21, Issue 13, 2015, Pages 1670-1680

  Hilven, Kelly ^a   Patsopoulos, Nikolaos A ^b   Dubois, Bénédicte ^c   Goris, An ^a  

^a KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

disease course; genetic association; genetic risk; IgG index; Multiple sclerosis; oligoclonal bands; relapse rate

Indexed keywords

HLA ANTIGEN; IMMUNOGLOBULIN G; OLIGOCLONAL BAND; CD45 ANTIGEN;

ADULT; ARTICLE; BELGIAN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BELGIUM; BLOOD; CEREBROSPINAL FLUID; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PHENOTYPE; RECURRENT DISEASE; RISK FACTOR; ASSESSMENT OF HUMANS; GENDER; MULTIPLE SCLEROSIS SEVERITY SCORE; RELAPSE;

ADULT; ALLELES; BELGIUM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; OLIGOCLONAL BANDS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; RISK FACTORS;

EID: 84986220369     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514568174     Document Type: Article

References (38)

1. Compston A, Coles A,. Multiple sclerosis. Lancet 2008; 372: 1502-1517.
2. International Multiple Sclerosis Genetics Consortium & Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
3. International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360.
4. Sawcer S, Franklin RJ, Ban M,. Multiple sclerosis genetics. Lancet Neurol 2014; 13: 700-709.
5. De Jager PL, Chibnik LB, Cui J, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurol 2009; 8: 1111-1119.
6. Sawcer S, Ban M, Wason J, et al. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3-10.
7. Gourraud PA, McElroy JP, Caillier SJ, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 2011; 69: 65-74.
8. Isobe N, Damotte V, Lo Re V, et al. Genetic burden in multiple sclerosis families. Genes Immun 2013; 14: 434-440.
9. Harbo HF, Isobe N, Berg-Hansen P, et al. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler 2013; 20: 660-668.
10. Sorosina M, Brambilla P, Clarelli F, et al. Genetic burden of common variants in progressive and bout-onset multiple sclerosis. Mult Scler 2014; 20: 802-811.
11. Disanto G, Dobson R, Pakpoor J, et al. The refinement of genetic predictors of multiple sclerosis. PLoS One 2014; 9: e96578.
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
13. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
14. Browning BL, Yu Z,. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Am J Hum Genet 2009; 85: 847-861.
15. Dilthey AT, Moutsianas L, Leslie S, et al. HLA∗IMP-an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 2011; 27: 968-972.
16. Sawcer S, Wason J,. Risk in complex genetics: €All models are wrong but some are useful€. Ann Neurol 2012; 72: 502-509.
17. Hensiek AE, Sawcer SJ, Feakes R, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72: 184-187.
18. Smestad C, Brynedal B, Jonasdottir G, et al. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol 2007; 14: 835-840.
19. Mero IL, Gustavsen MW, Saether HS, et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One 2013; 8: e58352.
20. Leone MA, Barizzone N, Esposito F, et al. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One 2013; 8: e64408.
21. Ebers GC,. Natural history of primary progressive multiple sclerosis. Mult Scler 2004; 10 (Suppl 1): S8-S13; discussion S13-S15.
22. Hensiek AE, Seaman SR, Barcellos LF, et al. Familial effects on the clinical course of multiple sclerosis. Neurology 2007; 68: 376-383.
23. Buck D, Albrecht E, Aslam M, et al. Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 2013; 73: 86-94.
24. Lin R, Taylor BV, Simpson S Jr, et al. Association between multiple sclerosis risk-associated SNPs and relapse and disability-a prospective cohort study. Mult Scler 2014; 20: 313-321.
25. Mowry EM, Carey RF, Blasco MR, et al. Multiple sclerosis susceptibility genes: Associations with relapse severity and recovery. PLoS One 2013; 8: e75416.
26. Balnyte R, Rastenyte D, Vaitkus A, et al. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neurol 2013; 13: 77.
27. Held U, Heigenhauser L, Shang C, et al. Predictors of relapse rate in MS clinical trials. Neurology 2005; 65: 1769-1773.
28. Tremlett H, Zhao Y, Joseph J, et al. Relapses in multiple sclerosis are age- and time-dependent. J Neurol Neurosurg Psychiatry 2008; 79: 1368-1374.
29. Young PJ, Lederer C, Eder K, et al. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis. Neurology 2006; 67: 804-808.
30. Van der Walt A, Stankovich J, Bahlo M, et al. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler 2011; 17: 344-352.
31. van Pelt ED, Mescheriakova JY, Makhani N, et al. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology 2013; 81: 1996-2001.
32. Roxburgh RHSR, Seaman SR, Masterman T, et al. Multiple sclerosis severity score: Using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.
33. Kantarci OH, Barcellos LF, Atkinson EJ, et al. Men transmit MS more often to their children vs women: The Carter effect. Neurology 2006; 67: 305-310.
34. Sawcer S,. The complex genetics of multiple sclerosis: Pitfalls and prospects. Brain 2008; 131: 3118-3131.
35. Herrera BM, Ramagopalan SV, Orton S, et al. Parental transmission of MS in a population-based Canadian cohort. Neurology 2007; 69: 1208-1212.
36. Sadovnick AD., Differential effects of genetic susceptibility factors in males and females with multiple sclerosis. Clin Immunol 2013; 149: 170-175.
37. Chao MJ, Ramagopalan SV, Herrera BM, et al. MHC transmission: Insights into gender bias in MS susceptibility. Neurology 2011; 76: 242-246.
38. Irizar H, Muñoz-Culla M, Zuriarrain O, et al. HLA-DRB1∗ 15:01 and multiple sclerosis: A female association? Mult Scler 2012; 18: 569-577.